E28.1 Description: Androgen excess Use Additional Code:
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Inclusion Term:
Hypersecretion of ovarian androgens
↓
E28 Description: Ovarian dysfunction Exclude1:
isolated gonadotropin deficiency (E23.0)
postprocedural ovarian failure (E89.4-)
↓
E20-E35 Description: Disorders of other endocrine glands (E20-E35) Exclude1:
galactorrhea (N64.3)
gynecomastia (N62)
↓
E00-E89 Description: Endocrine, nutritional and metabolic diseases Exclude1:
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Notes:
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.